Korro Bio, Inc. (KRRO)

NCM – Цена в реальном времени. Валюта: USD

11.22

-0.24 (-2.09%)

При закрытии: May 12, 2026, 4:00 PM EDT

11.22

0.00 (0.00%)

После закрытия: May 12, 2026, 4:27 PM EDT

Korro Bio, Inc. (KRRO)

Korro Bio, Inc. (KRRO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update

Korro to Participate in Upcoming Investor Conferences

What Makes Korro Bio, Inc. (KRRO) a New Buy Stock

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Korro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook

Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates

Видео

No Data

Пресс-релизы

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Search stocks

Korro Bio, Inc. (KRRO)

Korro Bio, Inc. (KRRO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update

Korro to Participate in Upcoming Investor Conferences

What Makes Korro Bio, Inc. (KRRO) a New Buy Stock

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Korro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook

Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates

Видео

No Data

Пресс-релизы

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update